Concepedia

Assessment of efficacy and safety of volanesorsen for treatment of metabolic complications in patients with familial partial lipodystrophy: Results of the BROADEN study

Elif A Oral, Abhimanyu Garg, Joseph A. Tami, Eric A. Huang, Louis O’Dea, H Schmidt, Anatoly Tiulpakov, Ann Mertens, Veronica J. Alexander, Lynnetta M. Watts,

Journal of clinical lipidology · 2022 · 69 citations · 16 references

DOI

Concepts

References

16

Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome

Joseph L. Witztum, Daniel Gaudet, Steven D. Freedman et al. · New England Journal of Medicine · 2019 · 669 citations · Full text

, , +17

Targeting APOC3 in the Familial Chylomicronemia Syndrome

Daniel Gaudet, Diane Brisson, Karine Tremblay et al. · New England Journal of Medicine · 2014 · 493 citations · Full text

, , +17

Accuracy of MR Imaging–estimated Proton Density Fat Fraction for Classification of Dichotomized Histologic Steatosis Grades in Nonalcoholic Fatty Liver Disease

An Tang, Ajinkya Desai, Gavin Hamilton et al. · Radiology · 2014 · 343 citations · Full text

, , +17

ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors

Philip L.S.M. Gordts, Ryan Nock, Ni-Huiping Son et al. · Journal of Clinical Investigation · 2016 · 260 citations · Full text

, , +17

Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Ioanna Gouni‐Berthold, Veronica J. Alexander, Qingqing Yang et al. · The Lancet Diabetes & Endocrinology · 2021 · 226 citations

, , +2